Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female ParticipantsActive Not Recruiting
NCT07190430Phase 1Updated Dec 9, 2025
Sponsor: Pfizer
Atopic Dermatitis
United States
Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus LetrozoleCompleted
NCT04735367N/AUpdated Dec 9, 2025
Sponsor: Pfizer
Breast Cancer
Japan
A Study to Understand How the Use of Paxlovid Affected the Healthcare Use in People With Pre-existing Conditions.Completed
NCT04550936N/AUpdated Dec 9, 2025
Sponsor: Pfizer
Invasive Aspergillosis · Mucormycosis
France, Germany, Italy, Spain, United Kingdom
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)Completed
NCT07086651N/AUpdated Dec 8, 2025
Sponsor: Pfizer
Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Cancer of the Prostate · Prostate Neoplasms · Prostate Cancer
United States
BESPONSA Injection 1 mg Special InvestigationCompleted
NCT05923112N/AUpdated Dec 5, 2025
Sponsor: Pfizer
Acute Lymphocytic Leukemia
Japan
Cardiac Amyloidosis Discovery TrialCompleted
NCT06469372NAUpdated Dec 4, 2025
Sponsor: Pierre Elias
Cardiac Amyloidosis
United States
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination ImmunotherapyCompleted
NCT05579847N/AUpdated Dec 4, 2025
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Renal Cell Carcinoma Stage IV
United States
Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens.Completed
NCT05253911N/AUpdated Dec 4, 2025
Sponsor: iOMEDICO AG
HER2-positive Breast Cancer
Austria, Germany
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.Completed
NCT06178991Phase 3Updated Dec 4, 2025
Sponsor: BioNTech SE
Influenza · COVID-19
United States
A Combination of Avelumab and Taxane (AVETAX) for Urothelial CancerCompleted
NCT03575013Phase 1Updated Dec 3, 2025
Sponsor: Yousef Zakharia
Urothelial Carcinoma
United States
Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed MyelomaRecruiting
NCT06947083Phase 2Updated Dec 3, 2025
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Myeloma
United States
A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaCompleted
NCT05687032Phase 4Updated Dec 3, 2025
Sponsor: Pfizer
Acute Lymphoblastic Leukemia
China
A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive CrisesCompleted
NCT04935879Phase 3Updated Dec 2, 2025
Sponsor: Pfizer
Sickle Cell Disease · Vaso-occlusive Pain Episode in Sickle Cell Disease · Vaso-occlusive Crisis
United States, Brazil, Colombia, Egypt, France +7 more
Mental Health Associations With VitiligoCompleted
NCT04953338N/AUpdated Dec 2, 2025
Sponsor: Momentum Data
Vitiligo · Depressive Episode · Recurrent Depressive Disorder · Anxiety Disorders
United Kingdom
A Study to Learn How the Study Medicine Called [14C]PF-07054894 is Processed by the BodyCompleted
NCT07009353Phase 1Updated Dec 2, 2025
Sponsor: Pfizer
Healthy
Netherlands
A Study to Learn About How Different Forms of Study Medicine PF-07248144 Are Taken Up Into the Blood in Healthy AdultsCompleted
NCT07117799Phase 1Updated Dec 1, 2025
Sponsor: Pfizer
Healthy Adults
United States
Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) StudiesActive Not Recruiting
NCT05226871Phase 2Updated Nov 25, 2025
Sponsor: Pfizer
Breast Cancer · Head and Neck Cancer
United States, China, Mexico, South Korea, Taiwan +2 more
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLCActive Not Recruiting
NCT03052608Phase 3Updated Nov 25, 2025
Sponsor: Pfizer
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Belgium, Canada +18 more
A Study to Learn How the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy AdultsTerminated
NCT06137729Phase 1Updated Nov 25, 2025
Sponsor: Pfizer
Healthy
Belgium
A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast CancerActive Not Recruiting
NCT06495164N/AUpdated Nov 25, 2025
Sponsor: Pfizer
Breast Cancer · Malignant Neoplasm of Breast
United States
A Study to Learn if the Study Medicine Called Carbamazepine Changes How the Body Processes PF-07220060Completed
NCT06897683Phase 1Updated Nov 25, 2025
Sponsor: Pfizer
Healthy Adults
United States
A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer PatientsActive Not Recruiting
NCT05266105Phase 1Updated Nov 24, 2025
Sponsor: Olema Pharmaceuticals, Inc.
Breast Cancer
Australia
Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®Completed
NCT03445637N/AUpdated Nov 24, 2025
Sponsor: Pfizer
Breast Neoplasm
South Korea
Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).Active Not Recruiting
NCT06581848N/AUpdated Nov 24, 2025
Sponsor: Pfizer
Multiple Myeloma
South Korea
Atrial Fibrillation Data Linkage Non-Interventional StudyCompleted
NCT05810727N/AUpdated Nov 20, 2025
Sponsor: Pfizer
Atrial Fibrillation
South Korea

Previous page Next page